InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Jackson Blair Curtis, Deputy Chief Executive. Director active across 1 companies, notably Alkermes plc.. Aggregated, 8 reports have been published. The latest transaction was disclosed on 20 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€762,66749,999 shares@ €15.25360.016% mcap42.4% of flow
Ordinary Shares
SEC:0001127602-22-012413:0·
4,589 shares
Ordinary Shares
SEC:0001127602-22-006309:0·
2,375 shares
Ordinary Shares
SEC:0001127602-22-005460:0·
2,375 shares
Ordinary Shares
SEC:0001127602-22-005460·
06,884 shares0
Ordinary Shares
SEC:0001127602-21-025404·
06,884 shares0
Ordinary Shares
SEC:0001127602-21-025404:0·
€517,92034,503 shares@ €15.01090.011% mcap100.0% of flow
Ordinary Shares
SEC:0001127602-21-015189·
€517,92034,503 shares@ €15.01090.011% mcap28.8% of flow
Ordinary Shares
SEC:0001127602-21-015189:0·
8 of 8 declarations
About Jackson Blair Curtis
Jackson Blair Curtis is the Executive Vice President and Chief Operating Officer of Alkermes plc. He plays a key role in managing the company's operations, contributing to the overall strategy and execution of initiatives. With expertise in the pharmaceutical sector, he is responsible for optimizing operational processes and improving efficiency. His leadership is essential for achieving the company's objectives and ensuring compliance with industry regulations.
